Pre-therapeutic comparative dosimetry of (177)Lu-rhPSMA-7.3 and (177)Lu-PSMAI&T in patients with metastatic castration resistant prostate cancer (mCRPC) - Feuerecker, B; Chantadisai, M; Allmann, A (J Nucl Med, 2021)